Document ID: chunk:federal_register_of_legislation:F2025L00053:clause:1_7
Version: federal_register_of_legislation:F2025L00053
Segment Type: clause
Provision Reference: sch 1 cl 7
Character Range: 8912–9277

7  Schedule 1 (table)
Omit:
Ramipril with felodipine  Tablet 2.5 mg‑2.5 mg (modified release)  Oral  Triasyn 2.5/2.5  4 months stock by reference to usual PBS demand

substitute:
Ramipril with felodipine  Tablet 2.5 mg-2.5 mg (modified release)  Oral  Triasyn 2.5/2.5  between 1 February 2025 and 30 September 2025—0 months stock by reference to usual PBS demand